Dispensing Error Prevention and Occurrence Risk
First written in FY2016. 19 of 21 entries say "Restated". Latest entry: FY2026.
3 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「As a precaution, all of the Group's dispensing pharmacies are covered by pharmacists' professional liability insurance. However, if a dispensing error occurs, this could affect the Group's results.」
It continues to identify measures to prevent dispensing errors, an auditing system, liability insurance coverage at all dispensing pharmacies and the risk of an impact on results if an error occurs. - FY2025RestatedAnnual report
「As a precaution, all of the Group's dispensing pharmacies are covered by pharmacists' professional liability insurance. However, if a dispensing error occurs, this could affect the Group's results.」
It continues to identify measures to prevent dispensing errors, an auditing system, liability insurance coverage at all dispensing pharmacies and the risk of an impact on results if an error occurs. - FY2024-Q3RestatedAnnual report
「During the nine-month period ended December 31, there were no new business risks or material changes to the business risks described in the securities report for the previous fiscal year.」
It states that there have been no material changes to the existing business and other risks, including the prevention of dispensing errors and the risk of their occurrence. - FY2022RestatedAnnual report
「As a precaution, all of the Group's dispensing pharmacies are covered by pharmacists' professional liability insurance. However, if a dispensing error occurs, this could affect the Group's results.」
It continues to cite guidelines, training, support systems, an auditing system and liability insurance coverage at all dispensing pharmacies as measures to prevent dispensing errors. - FY2022-Q3RestatedAnnual report
「During the nine-month period ended December 31, there were no new business risks or material changes to the business risks described in the securities report for the previous fiscal year.」
It states that there have been no material changes regarding the prevention of dispensing errors and the risk of their occurrence. - FY2022-Q2RestatedAnnual report
「During the six-month period ended September 30, there were no new business risks or material changes to the business risks described in the securities report for the previous fiscal year.」
It states that there have been no material changes regarding the prevention of dispensing errors and the risk of their occurrence. - FY2021MitigatedAnnual report
「As a precaution, all of the Group's dispensing pharmacies are covered by pharmacists' professional liability insurance. However, if a dispensing error occurs, this could affect the Group's results.」
It states that, in addition to guidelines and procedure manuals, training, support systems and an auditing system, all dispensing pharmacies are covered by pharmacists' professional liability insurance. - FY2021-Q3RestatedAnnual report
「During the nine-month period ended December 31, there were no new business risks or material changes to the business risks described in the securities report for the previous fiscal year.」
It is stated that there have been no material changes regarding the prevention of dispensing errors and the risk of their occurrence. - FY2021-Q2RestatedAnnual report
「During the six-month period ended September 30, there were no new business risks or material changes to the business risks described in the securities report for the previous fiscal year.」
It states that there have been no material changes regarding the prevention of dispensing errors and the risk of their occurrence. - FY2020-Q3RestatedAnnual report
「During the nine-month period ended December 31, there were no new business risks or material changes to the business risks described in the securities report for the previous fiscal year.」
It states that there have been no material changes regarding the prevention of dispensing errors and the risk of their occurrence. - FY2020-Q2RestatedAnnual report
「During the six-month period ended September 30, there were no new business risks or material changes to the business risks described in the securities report for the previous fiscal year.」
It states that there have been no material changes regarding the prevention of dispensing errors and the risk of their occurrence. - FY2020-Q1RestatedAnnual report
「During the three-month period ended June 30, there were no new business risks or material changes to the business risks described in the securities report for the previous fiscal year.」
It states that there have been no material changes regarding the prevention of dispensing errors and the risk of their occurrence. - FY2019RestatedAnnual report
「However, in the unlikely event of a dispensing error, it could affect the performance of the Group.」
It continues to identify the prevention of dispensing errors through guidelines and procedure manuals, pharmacist training, support systems and an auditing system, as well as the risk of an impact on results if an error occurs. - FY2019-Q3RestatedAnnual report
「During the nine-month period ended December 31, there were no new business risks or material changes to the business risks described in the securities report for the previous fiscal year.」
It states that there have been no material changes regarding the prevention of dispensing errors and the risk of their occurrence. - FY2019-Q2RestatedAnnual report
「During the six-month period ended September 30, there were no new business risks or material changes to the business risks described in the securities report for the previous fiscal year.」
It states that there have been no material changes regarding the prevention of dispensing errors and the risk of their occurrence. - FY2019-Q1RestatedAnnual report
「During the three-month period ended June 30, there were no new business risks or material changes to the business risks described in the securities report for the previous fiscal year.」
It states that there have been no material changes regarding the prevention of dispensing errors and the risk of their occurrence. - FY2018RestatedAnnual report
「However, in the unlikely event of a dispensing error, it could affect the performance of the Group.」
It continues to identify the prevention of dispensing errors through guidelines and procedure manuals, pharmacist training, support systems and an auditing system, as well as the risk of an impact on results if an error occurs. - FY2018-Q3RestatedAnnual report
「During the nine-month period ended December 31, there were no new business risks or material changes to the business risks described in the securities report for the previous fiscal year.」
It states that there have been no material changes regarding the prevention of dispensing errors and the risk of their occurrence. - FY2018-Q2RestatedAnnual report
「During the six-month period ended September 30, there were no new business risks or material changes to the business risks described in the securities report for the previous fiscal year.」
It states that there have been no material changes regarding the prevention of dispensing errors and the risk of their occurrence. - FY2017RestatedAnnual report
「However, in the unlikely event of a dispensing error, it could affect the performance of the Group.」
It continues to identify the prevention of dispensing errors through guidelines and procedure manuals, pharmacist training, support systems and an auditing system, as well as the risk of an impact on results if an error occurs. - FY2016First statedAnnual report
「However, in the unlikely event of a dispensing error, it could affect the performance of the Group.」
It cites guidelines and procedure manuals, pharmacist training, support systems and an auditing system as countermeasures.